Ftse Mib
38.298,77
0,19%
DAX
22.741,74
0,60%
S&P 500
5.614,56
-2,70%
NASDAQ
17.468,32
-4,00%
Bitcoin
81.648,07
4,05%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Novavax Inc (NVAX) Novavax Inc (NVAX) Notizie

Novavax Inc

NVAX
8,20
0,02 (0,24%)
Pre Mercato
Ultimo aggiornamento: 10:31:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202523:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202500:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202514:01EDGAR2Form 8-K - Current report
27/2/202522:05PRNUSNovavax to Participate in Upcoming March Investor..
27/2/202514:05EDGAR2Form 8-K - Current report
27/2/202514:00PRNUSNovavax Reports Fourth Quarter and Full Year 2024 Financial..
27/2/202513:41EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202514:00PRNUSNovavax to Host Conference Call to Discuss Fourth Quarter..
06/2/202501:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202501:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202500:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202513:50EDGAR2Form 8-K - Current report
03/1/202523:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202522:02EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
30/12/202423:27EDGAR2Form 8-K - Current report
26/12/202416:31EDGAR2Form 144 - Report of proposed sale of securities
18/12/202423:24EDGAR2Form 8-K - Current report
13/12/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202418:13EDGAR2Form 144 - Report of proposed sale of securities
13/12/202414:00PRNUSNovavax Advances Corporate Growth Strategy Through Sanofi..
10/12/202414:00PRNUSNovavax Initiates Phase 3 Trial for COVID-19-Influenza..
04/12/202412:00EDGAR2Form 8-K - Current report
04/12/202408:00PRNUSNovavax Announces Sale of Czech Republic Manufacturing Site..
15/11/202413:47PRNUSNovavax Announces Grant of Inducement Awards Pursuant to..
13/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202414:00PRNUSNovavax to Participate in Jefferies London Healthcare..
12/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202417:21EDGAR2Form 8-K - Current report
12/11/202414:04EDGAR2Form 8-K - Current report
12/11/202414:02PRNUSNovavax Reports Third Quarter 2024 Financial Results and..
11/11/202414:30PRNUSU.S. FDA Removes Clinical Hold on Novavax's..
05/11/202423:01EDGAR2Form 8-K - Current report
04/11/202422:30PRNUSNovavax to Host Conference Call to Discuss Third Quarter..
04/11/202412:00PRNUSÅsa Manelius Named Managing Director of Novavax AB Site
16/10/202414:14PRNUSUpdate on Novavax's COVID-19-Influenza Combination and..
16/10/202414:00EDGAR2Form 8-K - Current report
09/10/202413:00PRNUSNovavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine..
25/9/202414:00PRNUSNovavax Names Dr. Ruxandra Draghia-Akli as New Executive..
18/9/202422:08EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 8,18

La tua Cronologia

NASDAQ
NVAX
Novavax
BIT
NSCIT1390060
African Development Bank
BIT
HWVL
HSBC MSCI World Value ES...
BIT
I07906
Intesa Sanpaolo
BIT
F20408
Vontobel Financial Produ...
BIT
YKY
Yakkyo
BIT
SLVR
WisdomTree Silver
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci